Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.
about
Cannabis and psychosis/schizophrenia: human studiesThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinGlutamatergic substrates of drug addiction and alcoholismGone to Pot - A Review of the Association between Cannabis and PsychosisSpice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoidsDrug models of schizophreniaThe Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination.Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.A Review of Magnetic Resonance Spectroscopy Studies in Marijuana using Adolescents and Adults.Abnormal cerebellar morphometry in abstinent adolescent marijuana usersEffects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex.Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental modelsDrugs of abuse and increased risk of psychosis development.Ethanol-induced alterations of amino acids measured by in vivo microdialysis in rats: a meta-analysis.Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.Glutamatergic model psychoses: prediction error, learning, and inferenceDelta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography studyEndocannabinoid signaling in midbrain dopamine neurons: more than physiology?Involvement of the cannabinoid CB1 receptor in modulation of dopamine output in the prefrontal cortex associated with food restriction in rats.Acute effects of delta-9-tetrahydrocannabinol on performance monitoring in healthy volunteers.Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia.Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.Cannabinoid modulation of cortical adrenergic receptors and transporters.Role of Dopamine Type 1 Receptors and Dopamine- and cAMP-Regulated Phosphoprotein Mr 32 kDa in Δ9-Tetrahydrocannabinol-Mediated Induction of ΔFosB in the Mouse ForebrainUltrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons.Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.Cannabinoids and Schizophrenia: Risks and Therapeutic PotentialDrug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.Acute effects of THC on time perception in frequent and infrequent cannabis usersAlcohol inhibits luteinizing hormone-releasing hormone release by activating the endocannabinoid systemThe neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.Combined and independent effects of chronic marijuana use and HIV on brain metabolites.Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects.Endocannabinoid-mediated control of synaptic transmission.From drugs to deprivation: a Bayesian framework for understanding models of psychosis.The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogenThe effects of Δ9-tetrahydrocannabinol on the dopamine system.
P2860
Q24628837-4DC0B8AF-620F-4CF6-9FC5-FB221A0BB762Q24643876-9B589F6F-C896-4876-B042-994A6C334766Q24648924-EA247320-9B29-48C3-B9DF-CF4EE3183175Q26865311-0639C559-D911-4F45-877D-620D3EC1FD3EQ27010555-3613084B-E3A1-427D-854F-E29F63F81A83Q28084198-5EEBDFAE-DC8F-4739-8398-55EE785EF836Q30370881-8E11732B-28A5-4894-897B-E48049A4AA86Q30497212-E0AB0E28-3E54-489F-8E07-74AAD64ED7FCQ30768975-BDBD30FB-4980-4EA7-9125-C4A3B9D44154Q33838292-7D0A0514-850A-4C23-8511-70CA8BF7A886Q33886277-C567E8EA-710E-452D-9F5C-32E277E61A5EQ34001324-24F337CF-3D25-4BB5-B627-C03FF04F0CB2Q34098209-F20BB0E4-DE37-4068-9258-37DEEF4BBE85Q34290364-53314B36-0588-4E8C-BDC7-B140E9B7A23BQ34503542-35511B1F-AAEB-4704-8719-D1EE2947A642Q34613783-3245B214-3955-4359-87D2-4F53B25046B5Q34661231-16974F75-35D3-4D5F-B1DC-75C8267AA022Q34922727-1A25F58D-2998-46C8-A52B-B99307A0D2A3Q34967151-B81B148C-FCA6-4ED6-A3E6-C9AFB32F818CQ35121789-055E002E-3A6F-420D-8F85-A399ECD951BDQ35451180-9884D9B4-089B-4FE2-84B2-409B646B087DQ35612878-70FB1F30-7E89-41BE-8F12-2C01C622618FQ35626928-B6AA035E-0BAE-4C95-910C-08A33F05E8C6Q35754854-C3ADA686-4CA0-42A5-A11B-03CF9DA73F3BQ35962060-FE443AD9-3696-41ED-BBB2-C605B99B4D30Q35972392-A514FA69-3189-4587-B821-6299CBDC01F7Q35982298-C8F27148-331B-4CE1-BD1C-6350BE89A315Q36157669-0177FA32-2AAB-42E2-84DF-384CDB250366Q36417706-1030102E-7928-403A-B6AA-0B2C1E5888A5Q36636653-EFE8A68A-2597-4FE2-8BA5-16C6E0999040Q36855123-FB8D73BD-33FC-4918-B60D-F0A6CF9CA72EQ36965847-49B363B5-56B9-4270-8263-69FE9AB6F8E9Q36983868-2E5315CF-F022-4041-A742-4203DDAC3707Q37069544-06E5A972-B164-44AD-ADD6-3FDBFCA322E8Q37164807-B7CAF5F9-3507-46EF-9B0E-05597CCAF28BQ37341421-38529AF8-569A-4099-B14F-EB2BFE9C34BFQ37363621-BFA7D3BA-0FB2-4752-90CE-E898ADFFB4AAQ37370306-9F7DAD79-DF2F-4AD7-AE85-326A15DA0A76Q37416382-FC628532-AF3D-4BF0-8F4C-14CE167A9C20Q37441554-8674AFB0-757F-4D64-BF3E-D74882ECF5AD
P2860
Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Delta(9)-tetrahydrocannabinol ...... n in vivo microdialysis study.
@en
type
label
Delta(9)-tetrahydrocannabinol ...... n in vivo microdialysis study.
@en
prefLabel
Delta(9)-tetrahydrocannabinol ...... n in vivo microdialysis study.
@en
P2093
P50
P1433
P1476
Delta(9)-tetrahydrocannabinol ...... n in vivo microdialysis study.
@en
P2093
Gian Luigi Gessa
Luigi Pira
Marco Pistis
Paola Devoto
P304
P356
10.1016/S0006-8993(02)03055-X
P407
P577
2002-09-01T00:00:00Z